Drug:
Reaction: TREMOR
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26851935 |
US |
61 | 2 |
Tremor, Seizure, Haemoglobin decreased, White blood cell count decreased, Nephrolithiasis, Infection, Dyspepsia, Abdominal distension, Diarrhoea, Urinary tract infection, Fatigue, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 502 | 26851956 |
US |
1 | |
Major depression, Tardive dyskinesia, Tremor, |
||||
VALBENAZINE, CLOZAPINE, |
||||
| 503 | 26845904 |
CA |
79 | |
Tremor, Arthritis, Fear of injection, Insurance issue, |
||||
OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 504 | 26846071 |
US |
40 | 2 |
Hypotension, Toxicity to various agents, Respiratory depression, Myocardial injury, Pneumonitis aspiration, Tremor, Coma, Depression, Hyperreflexia, Ischaemia, Anion gap, Hepatotoxicity, Coagulopathy, Cardiac arrest, Clonus, |
||||
LORAZEPAM, PROPOFOL, |
||||
| 505 | 26846287 |
US |
1 | |
Tremor, |
||||
DUPILUMAB, |
||||
| 506 | 26846331 |
ZA |
41 | 2 |
Depression, Stress, Diabetes mellitus inadequate control, Diabetes mellitus inadequate control, Injection site haemorrhage, Weight decreased, Abdominal distension, Fatigue, Injection site pain, Weight increased, Glycosylated haemoglobin increased, Blood glucose increased, Hypoglycaemia, Tremor, Intentional dose omission, |
||||
INSULIN GLULISINE, INSULIN GLULISINE, INSULIN GLULISINE, INSULIN GLULISINE, INSULIN GLULISINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, ZOLPIDEM TARTRATE, |
||||
| 507 | 26846619 |
CA |
67 | 2 |
Catheter site erythema, Infusion site warmth, Muscle spasms, Musculoskeletal stiffness, Pain in extremity, Bradykinesia, Dyskinesia, Tremor, Mental fatigue, Fine motor skill dysfunction, Dizziness, Balance disorder, Catheter site discharge, Nausea, Vertigo, Catheter site erythema, Hallucination, auditory, Hallucination, visual, Nightmare, Infusion site discharge, Arthralgia, Infusion site bruising, Gait disturbance, Catheter site pain, Catheter site nodule, Pain in extremity, Gait inability, Therapeutic product effect incomplete, Memory impairment, Emotional disorder, Crying, Hypoaesthesia, Pain in extremity, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 508 | 26845198 |
US |
2 | |
Pyrexia, Rash, Muscle contractions involuntary, Tremor, Hypersensitivity, |
||||
ZILUCOPLAN, |
||||
| 509 | 26845371 |
US |
55 | 1 |
Agitation, Encephalopathy, Hallucinations, mixed, Hypertension, Tremor, Autonomic nervous system imbalance, Seizure, Toxicity to various agents, |
||||
BUPROPION HYDROCHLORIDE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 510 | 26845466 |
PK |
7 | 2 |
Disease recurrence, Respiratory distress, Febrile neutropenia, Back pain, Tachycardia, Generalised oedema, Hypertension, Tremor, |
||||
BLINATUMOMAB, |
||||
| 511 | 26849666 |
34 | 2 | |
Visual impairment, Blindness, Disorientation, Altered state of consciousness, Hyperhidrosis, Dizziness, Asthenia, Loss of consciousness, Pallor, Feeling cold, Contrast media reaction, Strabismus, Confusional state, Speech disorder, Restlessness, Muscle twitching, Tremor, Tremor, Headache, Vomiting, Toxic encephalopathy, Memory impairment, Mental status changes, Seizure, |
||||
GADOTERATE MEGLUMINE, |
||||
| 512 | 26849853 |
55 | 1 | |
Vomiting, Tremor, Unresponsive to stimuli, Encephalopathy, |
||||
BUPRENORPHINE, |
||||
| 513 | 26839683 |
US |
||
Tremor, Drug intolerance, |
||||
ORAL SEMAGLUTIDE, |
||||
| 514 | 26839935 |
US |
63 | 1 |
Parkinson^s disease, Freezing phenomenon, Loss of personal independence in daily activities, Gait disturbance, Tremor, Nausea, Drug effect less than expected, Therapy interrupted, Product use issue, Therapy cessation, |
||||
CARBIDOPA, CARBIDOPA TABLETS, LEVODOPA, PRAMIPEXOLE, ENTACAPONE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SERTRALINE, HYDROXYZINE PAMOATE, |
||||
| 515 | 26840145 |
US |
1 | |
Tremor, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 516 | 26840237 |
CN |
62 | 2 |
Myelosuppression, Tremor, Granulocyte count decreased, Seizure, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, IDARUBICIN HYDROCHLORIDE, VORICONAZOLE, VORICONAZOLE INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, STERILE WATER FOR INJECTION, |
||||
| 517 | 26840307 |
80 | 2 | |
Agitation, Anxiety, Ageusia, Asthenia, Balance disorder, Diarrhoea, Eye pain, Eye haemorrhage, Headache, Tremor, Coordination abnormal, Insomnia, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, GABAPENTIN, |
||||
| 518 | 26840347 |
IN |
31 | 1 |
Drug abuse, Insomnia, Hypothermia, Drug dependence, Anxiety, Hyperhidrosis, Pain, Lacrimation increased, Restlessness, Diarrhoea, Withdrawal syndrome, Intentional overdose, Tachycardia, Tremor, Rhinorrhoea, |
||||
ZOLPIDEM TARTRATE, TAPENTADOL HYDROCHLORIDE, |
||||
| 519 | 26840429 |
EU |
30 | 2 |
Pruritus, Agitation, Feeling abnormal, Heart rate increased, Decreased appetite, Dry mouth, Tremor, Palpitations, Hypoaesthesia, Asthenia, Irritability, |
||||
| 520 | 26840499 |
US |
69 | 2 |
Respiratory failure, Nasal polyps, Hemiparesis, Staphylococcal infection, Cardiac failure, Peroneal nerve palsy, Dyspnoea, Tremor, |
||||
AMBRISENTAN, DUPILUMAB, |
||||
| 521 | 26840544 |
MX |
20 | 1 |
Gastrointestinal haemorrhage, Tremor, |
||||
BLINATUMOMAB, |
||||
| 522 | 26840681 |
US |
2 | |
Hallucination, Tremor, Underdose, Off label use, |
||||
PIMAVANSERIN TARTRATE, GABAPENTIN, MEMANTINE, MEMANTINE HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 523 | 26841094 |
US |
86 | |
Fall, Loss of consciousness, Tremor, Malaise, |
||||
SIPULEUCEL-T, SIPULEUCEL-T, AMLODIPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 524 | 26841173 |
US |
73 | |
Feeling cold, Tremor, |
||||
SIPULEUCEL-T, SIPULEUCEL-T, ENZALUTAMIDE, BUPROPION, CYCLOBENZAPRINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, ROSUVASTATIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 525 | 26841177 |
US |
55 | 1 |
Encephalopathy, Hallucinations, mixed, Seizure, Hypertension, Autonomic nervous system imbalance, Agitation, Tremor, |
||||
BUPROPION, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 526 | 26841482 |
PH |
52 | |
Pneumonia, Blood glucose increased, Vomiting, Dizziness, Asthenia, Off label use, Ileus, Tremor, Hypoglycaemia, Limb injury, |
||||
| 527 | 26841668 |
GB |
2 | |
Medication error, Tremor, |
||||
NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 528 | 26841840 |
US |
2 | |
Tremor, Faeces discoloured, Fatigue, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, LEVOCETIRIZINE DIHYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, OXYGEN, 0XYGEN, LATANOPROST, NALTREXONE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, LORATADINE, LORATADINE ORAL, |
||||
| 529 | 26842302 |
CA |
56 | 2 |
Dizziness, Abdominal pain upper, Asthenia, Back pain, Blood cholesterol increased, Constipation, Injury, Injury associated with device, Loss of consciousness, Loss of personal independence in daily activities, Joint swelling, Limb injury, Nephrolithiasis, Pain, Pain, Pain in extremity, Pain in extremity, Peripheral swelling, Post procedural haemorrhage, Postmenopausal haemorrhage, Renal colic, Pulmonary oedema, Skin discolouration, Stress, Arthralgia, Contusion, Dyspnoea, Fatigue, Headache, Hypertension, Hypoaesthesia, Tremor, Visual impairment, Product dose omission issue, Product communication issue, Product availability issue, Device use confusion, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, BISOPROLOL FUMARATE, CYANOCOBALAMIN, CYANOCOBALAMIN, CYANOCOBALAMIN, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PRUCALOPRIDE, UPADACITINIB, RISEDRONATE SODIUM, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, SULFASALAZINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
| 530 | 26842363 |
84 | 2 | |
Vagus nerve disorder, Hallucination, Dysstasia, Tremor, Fatigue, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 531 | 26842490 |
PH |
63 | 1 |
Pyrexia, Abdominal discomfort, Myalgia, Disorientation, Speech disorder, Abdominal distension, Aphasia, Encephalitis, Tremor, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 532 | 26842855 |
CA |
||
Administration site pain, Hypertension, Nausea, Palpitations, Tachycardia, Tremor, Vomiting, Suspected off label use, |
||||
EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, |
||||
| 533 | 26843086 |
US |
87 | 1 |
Inadequate analgesia, Tremor, |
||||
BUPRENORPHINE, BUPRENORPHINE, |
||||
| 534 | 26843229 |
CA |
||
Administration site inflammation, Administration site pain, Bradycardia, Headache, Hypertension, Hypotension, Palpitations, Presyncope, Throat irritation, Tremor, Suspected off label use, |
||||
EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, |
||||
| 535 | 26843238 |
CA |
||
Administration site inflammation, Administration site pain, Dyspnoea, Hypertension, Palpitations, Tremor, Suspected off label use, |
||||
EPINEPHRINE, ADRENALINUM, |
||||
| 536 | 26843402 |
EU |
72 | 1 |
Immune effector cell-associated haematotoxicity, Immune effector cell-associated haematotoxicity, Bronchopulmonary aspergillosis, Febrile neutropenia, Immune effector cell-associated haematotoxicity, Oedema peripheral, Diarrhoea, Tremor, Nausea, Colour blindness, Speech disorder, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 537 | 26843535 |
EU |
46 | 2 |
Limb discomfort, Musculoskeletal stiffness, Cerebral infarction, Vertigo, Tremor, Skin disorder, Demyelination, Pain in extremity, Limb discomfort, Muscle spasms, |
||||
BUDESONIDE, VEDOLIZUMAB, ADALIMUMAB-ADAZ, MESALAMINE, |
||||
| 538 | 26843785 |
78 | 2 | |
Lower respiratory tract infection, Decreased appetite, Dyspnoea, Oral herpes, Fatigue, Feeling hot, Dizziness, Palpitations, Tremor, Hyperhidrosis, Abdominal discomfort, |
||||
LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, INDAPAMIDE, |
||||
| 539 | 26844383 |
EU |
2 | |
Muscle rigidity, Tremor, Drug interaction, |
||||
BUPROPION HYDROCHLORIDE, ARIPIPRAZOLE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, |
||||
| 540 | 26844492 |
US |
78 | 2 |
Schizophrenia, Tremor, Dyskinesia, |
||||
VALBENAZINE, VALBENAZINE, QUETIAPINE, QUETIAPINE, |
||||
| 541 | 26844597 |
EU |
36 | 2 |
Encephalitis toxic, Coma, Locked-in syndrome, Paralysis, Hypoacusis, Influenza like illness, Bronchitis, Anxiety, Tremor, Nightmare, Dizziness, Nausea, |
||||
SERTRALINE, BACLOFEN, DISULFIRAM, |
||||
| 542 | 26844666 |
US |
76 | 2 |
Tremor, |
||||
LENALIDOMIDE, |
||||
| 543 | 26844757 |
CA |
34 | 2 |
Infusion related reaction, Fatigue, Brain fog, Somnolence, Malaise, Paraesthesia, Mydriasis, Muscle contractions involuntary, Grimacing, Moaning, Pain, Dizziness, Tremor, Chest discomfort, Sinus congestion, Melanocytic naevus, Incorrect dosage administered, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 544 | 26844814 |
JP |
7 | 2 |
Intentional self-injury, Dystonia, Tremor, Product ineffective for unapproved use, Emotional distress, Insomnia, Off label use, |
||||
VALBENAZINE, VALBENAZINE, MIRTAZAPINE, LEMBOREXANT, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CLONAZEPAM, |
||||
| 545 | 26844886 |
US |
67 | 1 |
Depressed level of consciousness, Communication disorder, Tremor, On and off phenomenon, Device use error, Somnolence, Device occlusion, |
||||
FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 546 | 26844909 |
EU |
67 | 2 |
Fall, Spinal pain, Arthralgia, Tremor, On and off phenomenon, Sleep disorder, Fatigue, Catheter site discharge, Musculoskeletal disorder, Movement disorder, Gait disturbance, Compression fracture, Gait inability, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OPICAPONE, |
||||
| 547 | 26844922 |
US |
83 | 2 |
Asphyxia, Tremor, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 548 | 26846553 |
45 | ||
Myalgia, Brain fog, Tremor, Dysstasia, Gait disturbance, Muscular weakness, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 549 | 26849474 |
63 | 2 | |
Tremor, Dizziness, Constipation, Delusion, Thinking abnormal, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, QUETIAPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, |
||||
| 550 | 26834494 |
US |
63 | 2 |
Psoriatic arthropathy, Psoriasis, Headache, Acne, Fatigue, Pain, Tremor, Sensitive skin, Varicella meningitis, Lumbar puncture, Hypersomnia, Vertigo, Gait disturbance, Sunburn, Hyperaesthesia eye, Insomnia, Loss of personal independence in daily activities, |
||||
UPADACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 551 | 26834526 |
CA |
37 | 2 |
Loss of consciousness, Hyperhidrosis, Infusion site pruritus, Sleep deficit, Infusion site mass, Infusion site nodule, Dyskinesia, Road traffic accident, Foot fracture, Syringe issue, Device adhesion issue, Infusion site cellulitis, Catheter site infection, Catheter site mass, Catheter site nodule, Catheter site pruritus, Vomiting, Tremor, Product administration error, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, BUPROPION, LISDEXAMFETAMINE DIMESYLATE, PRAZOSIN, QUETIAPINE, |
||||
| 552 | 26835049 |
EU |
76 | 1 |
Stoma site inflammation, Device dislocation, Musculoskeletal stiffness, Stoma site reaction, Movement disorder, Stoma site pain, Mobility decreased, On and off phenomenon, Gastrooesophageal reflux disease, Trismus, Nausea, Gait disturbance, Muscle rigidity, Overdose, Device physical property issue, Fibroma, Joint stiffness, Stoma site erythema, Restlessness, Choking, Incorrect dose administered, Dyskinesia, Stoma site pain, Device leakage, Stoma site discharge, Tension, Nocturia, Stoma site reaction, Stoma site induration, Tremor, Balance disorder, Reduced facial expression, Fatigue, Therapeutic product effect incomplete, Speech disorder, Asthenia, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 553 | 26835222 |
EU |
13 | 2 |
Sedation, Weight increased, Drug ineffective, Akathisia, Tremor, Drug intolerance, Therapeutic product effect decreased, Off label use, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CLOZAPINE, CLOZAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, RISPERIDONE, RISPERIDONE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 554 | 26835405 |
EU |
46 | 2 |
Vertigo, Tremor, Limb discomfort, Musculoskeletal stiffness, Demyelination, Cerebral infarction, Skin disorder, Limb discomfort, Pain in extremity, Muscle spasms, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, VEDOLIZUMAB, BUDESONIDE, MESALAMINE, |
||||
| 555 | 26835436 |
US |
67 | 2 |
Dyskinesia, Tremor, |
||||
TERIPARATIDE, |
||||
| 556 | 26835574 |
US |
73 | 2 |
Tremor, Chills, Urinary incontinence, Muscular weakness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 557 | 26835862 |
CA |
69 | |
Feeling cold, Tremor, Cardiac disorder, Neoplasm malignant, Nasopharyngitis, Arthralgia, Inappropriate schedule of product administration, Drug ineffective, |
||||
RITUXIMAB, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, |
||||
| 558 | 26836021 |
US |
2 | |
Thyroidectomy, Tremor, Hypothyroidism, Lymphadenopathy, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 559 | 26836358 |
US |
2 | |
Hallucination, Tremor, Vitamin B12 deficiency, |
||||
PIMAVANSERIN TARTRATE, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, DEXLANSOPRAZOLE, CARBIDOPA AND LEVODOPA, |
||||
| 560 | 26836382 |
GB |
2 | |
Unresponsive to stimuli, Malaise, Pollakiuria, Hot flush, Abdominal distension, Dyspnoea, Fatigue, Tremor, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 561 | 26836647 |
US |
63 | |
Suicidal ideation, Thyroid function test abnormal, High density lipoprotein decreased, Blood cholesterol abnormal, Dark circles under eyes, Insomnia, Tremor, Dyspnoea, COVID-19, Blood alkaline phosphatase abnormal, Feeling abnormal, Condition aggravated, Heart rate decreased, Palpitations, Depressed mood, |
||||
RESMETIROM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, RABEPRAZOLE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 562 | 26836822 |
US |
61 | 2 |
Tremor, Accidental exposure to product, Exposure via skin contact, Product dose omission in error, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 563 | 26836952 |
EU |
28 | 1 |
Circulatory collapse, Cardiovascular disorder, Skin odour abnormal, Presyncope, Loss of personal independence in daily activities, Hypotonia, Vertigo, Muscular weakness, Hyperhidrosis, Tremor, Labelled drug-drug interaction issue, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 564 | 26837109 |
US |
35 | 2 |
Agitation, Abnormal behaviour, Mania, Anxiety, Palpitations, Tachyphrenia, Confusional state, Insomnia, Somnolence, Lactation disorder, Back pain, Tremor, Asthenia, Fatigue, |
||||
ZURANOLONE, ZURANOLONE, ZURANOLONE, FLUTICASONE PROPIONATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 565 | 26837367 |
US |
80 | 2 |
Tremor, Activities of daily living decreased, Headache, Nausea, |
||||
VIBEGRON, |
||||
| 566 | 26837899 |
GB |
66 | 2 |
Tremor, Fear, Confusional state, Chest discomfort, Dyspnoea, Paraesthesia, Dry mouth, Cold sweat, Nausea, Panic attack, Dizziness, Hyperhidrosis, |
||||
CLARITHROMYCIN, |
||||
| 567 | 26838174 |
CA |
||
Administration site pain, Anxiety, Catheter site related reaction, Dyspepsia, Dyspnoea, Hypertension, Tachycardia, Tremor, Suspected off label use, |
||||
EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, |
||||
| 568 | 26838401 |
EU |
80 | 2 |
Hip fracture, Hallucination, auditory, Bradykinesia, On and off phenomenon, Tremor, Fatigue, Reduced facial expression, Catheter site pain, Dizziness, Muscle rigidity, Asthenia, Dyskinesia, Infusion site bruising, Catheter site induration, Catheter site erythema, Insomnia, Motor dysfunction, Therapeutic product effect incomplete, Contusion, Skin induration, Drug ineffective, Fall, Somnolence, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ROPINIROLE, |
||||
| 569 | 26838441 |
US |
62 | 2 |
Deafness unilateral, Ill-defined disorder, Feeling jittery, Tremor, Product dispensing error, Accidental overdose, |
||||
BUPROPION, BUPROPION, BUPROPION, |
||||
| 570 | 26838448 |
NI |
64 | 1 |
Myalgia, Chills, Dry mouth, Chest pain, Tremor, |
||||
IOVERSOL, |
||||
| 571 | 26838508 |
NI |
28 | 2 |
Tremor, Tachycardia, Myalgia, Arthralgia, Dry mouth, Headache, Chills, Vomiting, Abdominal pain upper, |
||||
IOVERSOL, |
||||
| 572 | 26838542 |
CA |
||
Administration site inflammation, Administration site pain, Headache, Hypertension, Nausea, Palpitations, Tachycardia, Tremor, Vomiting, Suspected off label use, |
||||
EPINEPHRINE, ADRENALINUM, |
||||
| 573 | 26838741 |
CA |
75 | 1 |
Death, Parkinsonism, Hospitalisation, Therapy cessation, Tremor, Infusion site discharge, Nausea, Vomiting, Constipation, Device use issue, Syringe issue, Incorrect dose administered, Nausea, Vomiting, Weight decreased, Feeding disorder, Asthenia, Dehydration, Fluid intake reduced, Dysphagia, Weight decreased, Device connection issue, Product use issue, |
||||
LEVODOPA, GABAPENTIN, IRON, CALCIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, HUMAN IMMUNOGLOBULIN G, |
||||
| 574 | 26839228 |
US |
1 | |
Urinary retention, Angioedema, Tremor, |
||||
VALBENAZINE, VALBENAZINE, |
||||
| 575 | 26839437 |
US |
75 | 1 |
Prostatic operation, Feeling abnormal, Foot deformity, Dyspnoea, Device issue, On and off phenomenon, Tremor, Catheter site pain, Device use error, Skin mass, Product administered at inappropriate site, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 576 | 26841792 |
1 | ||
Tremor, Speech disorder, Disturbance in attention, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 577 | 26829860 |
55 | 1 | |
Impaired gastric emptying, Tremor, Confusional state, Dysphagia, Choking sensation, |
||||
DULAGLUTIDE, |
||||
| 578 | 26830030 |
US |
1 | |
Tremor, Hyperhidrosis, Back pain, Feeling cold, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 579 | 26830094 |
US |
||
Feeling abnormal, Therapeutic product effect incomplete, Tremor, Disturbance in attention, Tic, |
||||
BACLOFEN, |
||||
| 580 | 26830438 |
EU |
73 | 2 |
Arrhythmia, Hypertensive crisis, Tremor, Dysphonia, Blood pressure systolic increased, Drug intolerance, |
||||
ALBUTEROL SULFATE, ALBUTEROL, AMIKACIN, |
||||
| 581 | 26830532 |
US |
41 | |
Feeling abnormal, Pollakiuria, Tinnitus, Nasopharyngitis, Tremor, Abdominal discomfort, Psychogenic seizure, Musculoskeletal discomfort, Joint swelling, |
||||
TOLVAPTAN, TOLVAPTAN, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 582 | 26830710 |
US |
2 | |
Fatigue, Tremor, Blood iron decreased, Drug ineffective, |
||||
RAVULIZUMAB, |
||||
| 583 | 26830767 |
GB |
79 | 2 |
Fluid retention, Diarrhoea, Tremor, |
||||
LINAGLIPTIN, DAPAGLIFLOZIN, INDAPAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LATANOPROST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 584 | 26830968 |
US |
||
Tremor, Dysstasia, |
||||
GLYCOPYRROLATE AND FORMOTEROL FUMARATE, |
||||
| 585 | 26831107 |
US |
||
Chills, Tremor, |
||||
DONANEMAB-AZBT, |
||||
| 586 | 26831473 |
PA |
2 | |
Postictal paralysis, Epilepsy, Hyperhidrosis, Tremor, Asthenia, Vomiting, |
||||
BLINATUMOMAB, BLINATUMOMAB, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 587 | 26831514 |
CA |
36 | 1 |
Rectal haemorrhage, Tremor, Impaired work ability, Abdominal pain, Feeling abnormal, Gastrointestinal inflammation, Loss of consciousness, Ulcer, Drug ineffective, Diarrhoea, Diarrhoea, Pallor, Fluid intake reduced, Feeding disorder, Insomnia, Haematochezia, Impaired quality of life, Abdominal pain, Haematochezia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 588 | 26831725 |
US |
||
Tremor, |
||||
| 589 | 26831912 |
EU |
28 | 1 |
Circulatory collapse, Cardiovascular disorder, Muscular weakness, Loss of personal independence in daily activities, Hypotonia, Labelled drug-drug interaction issue, Skin odour abnormal, Vertigo, Hyperhidrosis, Tremor, Presyncope, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PANTOPRAZOLE, |
||||
| 590 | 26831960 |
EU |
73 | 1 |
Hallucination, Disorientation, Agitation, Aggression, Tremor, On and off phenomenon, Movement disorder, Musculoskeletal stiffness, Gait disturbance, Freezing phenomenon, Discomfort, Somnolence, Malaise, Incorrect dose administered, Drug ineffective, Off label use, Therapeutic product effect delayed, |
||||
QUETIAPINE, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 591 | 26832612 |
BR |
39 | 2 |
Asthenia, Headache, Nausea, Tremor, Product substitution issue, |
||||
ADALIMUMAB-ADAZ, |
||||
| 592 | 26833026 |
GB |
57 | 1 |
Multiple sclerosis, Fatigue, Balance disorder, Brain fog, Tremor, Lethargy, Chills, Fatigue, Headache, Pyrexia, Influenza, Chills, Weight increased, Therapeutic response shortened, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 593 | 26833344 |
US |
2 | |
Drug dependence, Sciatica, Paraesthesia, Burning sensation, Abdominal pain upper, Fibromyalgia, Pain, Tremor, |
||||
OXYCODONE HYDROCHLORIDE, BUPRENORPHINE, HYDROCODONE BITARTRATE, |
||||
| 594 | 26833445 |
US |
||
Tremor, |
||||
LINEZOLID, PRETOMANID, |
||||
| 595 | 26833476 |
78 | 2 | |
Urinary tract infection, Tremor, Pyrexia, Discouragement, Malaise, Decreased appetite, |
||||
FINERENONE, |
||||
| 596 | 26833499 |
GB |
2 | |
Unresponsive to stimuli, Malaise, Pollakiuria, Hot flush, Tremor, Abdominal distension, Fatigue, Hyperventilation, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 597 | 26833840 |
US |
68 | 2 |
Vomiting projectile, Migraine, Asthenia, Nausea, Tremor, Dizziness, Fatigue, Constipation, |
||||
TIRZEPATIDE, |
||||
| 598 | 26833870 |
EU |
46 | 2 |
Pain in extremity, Muscle spasms, Limb discomfort, Musculoskeletal stiffness, Vertigo, Tremor, Cerebral infarction, Demyelination, Skin disorder, |
||||
VEDOLIZUMAB, ADALIMUMAB-ADAZ, BUDESONIDE, MESALAMINE, |
||||
| 599 | 26833886 |
US |
77 | 1 |
Brain injury, Suicide attempt, Restlessness, Nervous system disorder, Taciturnity, Dyskinesia, Anxiety, Somnolence, Tremor, Product use in unapproved indication, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, ARIPIPRAZOLE, PAROXETINE HYDROCHLORIDE, |
||||
| 600 | 26834268 |
2 | ||
Insomnia, Tremor, |
||||
OLANZAPINE AND SAMIDORPHAN L-MALATE, OLANZAPINE AND SAMIDORPHAN L-MALATE, OLANZAPINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
